J. Hansen

发表

Factors governing long‐term adherence to a gluten‐free diet in adult patients with coeliac disease

D. Leffler, C. Kelly, M. Dennis, 2015, Alimentary pharmacology & therapeutics.

Socioeconomic Risk Factors for Celiac Disease Burden and Symptoms

D. Leffler, C. Kelly, M. Dennis, 2016, Journal of clinical gastroenterology.

Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease

D. Schuppan, J. Goldsmith, D. Leffler, 2012, Gut.

Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantiﬁcation of Clostridium difﬁcile Toxins in Stool

D. Duffy, D. Gerding, Linan Song, 2015 .

Despite sequence homologies to gluten, salivary proline-rich proteins do not elicit immune responses central to the pathogenesis of celiac disease.

D. Schuppan, J. Murray, E. Marietta, 2015, American journal of physiology. Gastrointestinal and liver physiology.

Serum IgA in Celiac Disease: The Unrecognized Importance of Partial IgA Deficiency

D. Schuppan, D. Leffler, C. Kelly, 2011 .

Clostridioides difficile Toxin A Remodels Membranes and Mediates DNA Entry Into Cells to Activate Toll Like Receptor 9 Signaling.

D. Golenbock, G. Wong, M. Grant, 2020, Gastroenterology.

Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis

D. Paredes-Sabja, C. Pothoulakis, Y. Shah, 2018, Nature Microbiology.

Low testosterone in non-responsive coeliac disease: A case series, case-control study with comparisons to the National Health and Nutrition Examination Survey.

D. Leffler, C. Kelly, J. Hansen, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Pancreatic enzyme supplementation versus placebo for improvement of gastrointestinal symptoms in non-responsive celiac disease: A cross-over randomized controlled trial

J. Silvester, D. Leffler, C. Kelly, 2023, Frontiers in Medicine.

Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers

S. Dowd, D. Leffler, C. Kelly, 2016, Gut microbes.

Salivary Gluten Degradation and Oral Microbial Profiles in Healthy Individuals and Celiac Disease Patients

D. Schuppan, B. Paster, L. Faller, 2017, Applied and Environmental Microbiology.

Patients with celiac disease have a lower prevalence of non-insulin-dependent diabetes mellitus and metabolic syndrome.

R. Betensky, D. Leffler, C. Kelly, 2013, Gastroenterology.

Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in Stool

D. Duffy, D. Gerding, Linan Song, 2015, Journal of Clinical Microbiology.

Noncoeliac enteropathy: the differential diagnosis of villous atrophy in contemporary clinical practice

D. Leffler, C. Kelly, K. Pallav, 2012, Alimentary pharmacology & therapeutics.

Celiac Disease or Non-Celiac Gluten Sensitivity? An Approach to Clinical Differential Diagnosis

D. Leffler, C. Kelly, K. Pallav, 2014, The American Journal of Gastroenterology.

Prevalence of Abnormal Liver Function Tests in Celiac Disease and the Effect of a Gluten-Free Diet in the US Population

J. Murray, D. Leffler, C. Kelly, 2015, The American Journal of Gastroenterology.

Response to Aziz et al.

D. Leffler, C. Kelly, K. Pallav, 2014, The American Journal of Gastroenterology.

Effects of polysaccharopeptide from Trametes Versicolor and amoxicillin on the gut microbiome of healthy volunteers

S. Dowd, D. Newburg, D. Leffler, 2014, Gut microbes.

Body mass index and the risk of obesity in coeliac disease treated with the gluten‐free diet

D. Leffler, C. Kelly, K. Pallav, 2012, Alimentary pharmacology & therapeutics.

Salivary proline‐rich proteins and gluten: Do structural similarities suggest a role in celiac disease?

D. Schuppan, T. Cabras, I. Messana, 2015, Proteomics. Clinical applications.

Patient Perception of Treatment Burden Is High in Celiac Disease Compared With Other Common Conditions

D. Leffler, C. Kelly, S. Shah, 2014, The American Journal of Gastroenterology.

Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis

D. Paredes-Sabja, C. Pothoulakis, Y. Shah, 2018, Nature Microbiology.

Celiac Disease Symptom Frequency and Severity Using A Disease‐Specific Patient‐Reported Outcome Diary: Observations From A Psychometric Validation Study in 202 Patients: 1509

S. Acaster, D. Leffler, B. Lebwohl, 2012 .

Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers

S. Dowd, D. Leffler, C. Kelly, 2016, Gut microbes.